CONTEXT: It is often difficult to find an adenoma in patients with Cushing's disease (CD) whose preoperative magnetic resonance imaging (MRI) is normal. Better localizing modalities are needed. OBJECTIVE: The aim of this study was to determine the accuracy of inferior petrosal sinus sampling (IPSS) in predicting adenoma lateralization. DESIGN AND SETTING: We conducted a prospective observational study at a tertiary care clinical research center. PATIENTS: A total of 501 consecutive patients (363 female) with confirmed ACTH adenomas and IPSS were included. MAIN OUTCOME MEASURE: We measured the accuracy of IPSS to predict the intrasellar location of an adenoma. RESULTS: IPSS confirmed a pituitary source of ACTH secretion in 491 patients (98%). All 10 patients with false-negative results had peak IPSS ACTH concentrations (before or after CRH) of < 400 pg/ml. Interpetrosal (side-to-side) ratios were ≥ 1.4 in 491 patients (98%). This ratio correctly predicted lateralization in 273 of 396 patients (positive predictive value = 69%) with a lateral adenoma. Left-sided IPSS lateralization (P = .008) and consistent lateralization before and after CRH administration (P = .02) were associated with enhanced accuracy. When positive, preoperative MRI correlated with adenoma location in 171 of 201 patients (positive predictive value = 86%). CONCLUSIONS: Potential false-negative results, the most common type of diagnostic error with IPSS for the differential diagnosis of CS, can be identified by peak IPSS ACTH values < 400 pg/ml. When MRI is normal, IPSS can be used to guide surgical exploration in patients with negative preoperative imaging. However, because of the limited accuracy of lateralization, thorough exploration of the pituitary gland is required when an adenoma is not readily discovered based on predicted location.
CONTEXT: It is often difficult to find an adenoma in patients with Cushing's disease (CD) whose preoperative magnetic resonance imaging (MRI) is normal. Better localizing modalities are needed. OBJECTIVE: The aim of this study was to determine the accuracy of inferior petrosal sinus sampling (IPSS) in predicting adenoma lateralization. DESIGN AND SETTING: We conducted a prospective observational study at a tertiary care clinical research center. PATIENTS: A total of 501 consecutive patients (363 female) with confirmed ACTHadenomas and IPSS were included. MAIN OUTCOME MEASURE: We measured the accuracy of IPSS to predict the intrasellar location of an adenoma. RESULTS: IPSS confirmed a pituitary source of ACTH secretion in 491 patients (98%). All 10 patients with false-negative results had peak IPSS ACTH concentrations (before or after CRH) of < 400 pg/ml. Interpetrosal (side-to-side) ratios were ≥ 1.4 in 491 patients (98%). This ratio correctly predicted lateralization in 273 of 396 patients (positive predictive value = 69%) with a lateral adenoma. Left-sided IPSS lateralization (P = .008) and consistent lateralization before and after CRH administration (P = .02) were associated with enhanced accuracy. When positive, preoperative MRI correlated with adenoma location in 171 of 201 patients (positive predictive value = 86%). CONCLUSIONS: Potential false-negative results, the most common type of diagnostic error with IPSS for the differential diagnosis of CS, can be identified by peak IPSS ACTH values < 400 pg/ml. When MRI is normal, IPSS can be used to guide surgical exploration in patients with negative preoperative imaging. However, because of the limited accuracy of lateralization, thorough exploration of the pituitary gland is required when an adenoma is not readily discovered based on predicted location.
Authors: E H Oldfield; G P Chrousos; H M Schulte; M Schaaf; P E McKeever; A G Krudy; G B Cutler; D L Loriaux; J L Doppman Journal: N Engl J Med Date: 1985-01-10 Impact factor: 91.245
Authors: Nicholas Patronas; Nail Bulakbasi; Constantine A Stratakis; Antony Lafferty; Edward H Oldfield; John Doppman; Lynnette K Nieman Journal: J Clin Endocrinol Metab Date: 2003-04 Impact factor: 5.958
Authors: E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux Journal: N Engl J Med Date: 1991-09-26 Impact factor: 91.245
Authors: Russell R Lonser; Joshua J Wind; Lynnette K Nieman; Robert J Weil; Hetty L DeVroom; Edward H Oldfield Journal: J Clin Endocrinol Metab Date: 2013-01-31 Impact factor: 5.958
Authors: Chienying Liu; Joan C Lo; Christopher F Dowd; Charles B Wilson; Sandeep Kunwar; David C Aron; J Blake Tyrrell Journal: Clin Endocrinol (Oxf) Date: 2004-10 Impact factor: 3.478
Authors: Gautam U Mehta; Blake K Montgomery; Pooja Raghavan; Susmeeta Sharma; Lynnette K Nieman; Nicholas Patronas; Edward H Oldfield; Prashant Chittiboina Journal: J Clin Neurosci Date: 2015-03-29 Impact factor: 1.961
Authors: Hai Sun; Chris Yedinak; Alp Ozpinar; Jim Anderson; Aclan Dogan; Johnny Delashaw; Maria Fleseriu Journal: J Neurol Surg B Skull Base Date: 2015-01-21
Authors: Lynnette K Nieman; Beverly M K Biller; James W Findling; M Hassan Murad; John Newell-Price; Martin O Savage; Antoine Tabarin Journal: J Clin Endocrinol Metab Date: 2015-07-29 Impact factor: 5.958